Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and hTERT down-regulation

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 2305-2309

  Noureini, Sakineh Kazemi ^a   Wink, Michael ^b  

^a HAKIM SABZEVARI UNIVERSITY   (Iran)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Crocin; Hepatocarcinoma; hTERT; Telomerase

Indexed keywords

CAROTENOID; CROCIN; TELOMERASE; TERT PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERE; TUMOR CELL CULTURE;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CAROTENOIDS; CELL PROLIFERATION; HUMANS; LIVER NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TELOMERE; TUMOR CELLS, CULTURED;

EID: 84872686984     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.2305     Document Type: Article

References (46)

1. Abdullaev FI, Espinosa-Aguirre JJ (2004). Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev, 28, 426-32.
2. 3n-Negrete L, Caballero-Ortega H, et al (2003). Use of in vitro assays to assess the potential antigenotoxic and cytotoxic effects of saffron (Crocus sativus L.). Toxicol In Vitro, 17, 731-6.
3. Abdullaev JF, Caballero-Ortega H, Riverón-Negrete L, et al (2002). In vitro evaluation of the chemopreventive potential of saffron. Rev Invest Clin, 54, 430-6.
4. Akhondzadeh S, Fallah-Pour H, Afkham K, et al (2004). Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression, A pilot double-blind randomized trial. BMC Complementary Alternative Med, 4, 12,
5. Aung HH, Wang CZ, Ni M, et al (2007). Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol, 29, 175-80.
6. Bakshi H, Sam S, Rozati R, et al (2010). DNA fragmentation and cell cycle arrest, A Hallmark of apoptosis induced by crocin from Kashmiri saffron in a human pancreatic cancer cell line. Asian Pacific J Cancer Prev, 11, 675-9.
7. Bakshi HA, Sam S, Feroz A, et al (2009). Crocin from Kashmiri saffron (Crocus sativus) induces in vitro and in vivo xenograft growth inhibition of Dalton's lymphoma (DLA) in mice. Asian Pac J Cancer Prev, 10, 887-90.
8. Blackburn E, Greider C (1995). Telomeres. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
9. Blackburn EH (2001). Switching and signaling at the telomere. Cell, 106, 661-73.
10. Borenfreund E, Bbich H, Martin-Alguacil N, (1990). Rapid chemosensitivity assay with human normal and tumor cells in vitro. In Vitro Cell Dev Biol, 26, 1030-4.
11. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72, 248-54.
12. Chryssanthi DG, Lamari FN, Iatrou G, et al (2007). Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. Anticancer Res, 27, 357-62.
13. Damm K, Hemmann U, Garin-Chesa P, et al (2001). A highly selective telomerase inhibitor limiting human cancer cell proliferation. The EMBO J, 20, 6958-68.
14. Ebrahim-Habibi MB, Amininasab M, Ebrahim-Habibi A, et al. (2010) Fibrillation of alpha-lactalbumin: effect of crocin and safranal, two natural small molecules from Crocus sativus. Biopolymers. 93, 854-65.
15. Escribano J, Alonso GL, Coca-Prados M, et al (1996). Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett, 100, 22-30.
16. Ghadrdoost B, Vafaei AA, Rashidy-Pour A, et al (2011) Protective effects of saffron extract and its active constituent crocin against oxidative stress and spatial learning andmemory deficits induced by chronic stress in rats. Eur J Pharmacol, 667, 222-9.
17. Gunes C, Lichtsteiner S, Vasserot AP, et al (2000). Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res, 60, 2116-21.
18. Hahn WC, Stewart SA, Brooks MW, et al (1999). Inhibition of telomerase limits the growth of human cancer cells. Nature Med, 5, 1164-70.
19. Hariri AT, Moallem SA, Mahmoudi M, et al (2011). The effect of crocin and safranal, constituents of saffron, against subacute effect of diazinon on hematological and genotoxicity indices in rats. Phytomedicine, 18, 499-504.
20. Hiyama E, Yokoyama T, Tatsumoto N, et al (1995). Telomerase activity in gastric cancer. Cancer Res, 55, 3258-62.
21. Hosseinzadeh H, Sadeghnia HR, Ghaeni FA, et al (2012) Effects of saffron (Crocus sativus L.) and its active constituent, crocin, on recognition and spatial memory after chronic cerebral hypoperfusion in rats. Phytother Res, 26, 381-6.
22. Hou M, Dawei X, Bjorkholm M, et al (2001). Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Clin Chem, 47, 519-24
23. Huffman KE, Levene SD, Tesmer VM, et al (2000). Telomere shortening is proportional to the size of the G-rich telomeric 3'-overhang. J Biol Chem, 26, 19719-22.
24. Kazemi Noureini S, Ziaee AA, Rastegar-Jazii F, et al (2004). Telomerase activity in Iranian patients with esophageal squamous cell carcinoma. Med J Islamic Republic Iran, 2, 147-52.
25. Kazemi Noureini S, Wink M (2009). Transcriptional down regulation of hTERT and induction of senescence in HepG2 cells by the benzophenanthridine alkaloid chelidonine. World J Gastroenterol, 15, 3603-10.
26. Kondo S, Kondo Y, Li G, et al (1998). Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene, 16, 3323-30.
27. Konoshima T, Takasaki M (2003). Anti-carcinogenic activities of natural pigments from beet root and saffron. Foods Food Ingredients J, 208, 615-22.
28. Li S, Rosenberg J, Donjacour A, et al (2004). Inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res, 64, 4833-40.
29. Ludwig A, Saretzki G, Holm PS, et al (2001). Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase. Cancer Res, 61, 3053-61.
30. Mehri S, Abnous K, Mousavi SH, et al (2012) Neuroprotective effect of crocin on acrylamide-induced cytotoxicity in PC12 cells. Cell Mol Neurobiol, 32, 227-35.
31. Mergny JL, Lacroix L, Teulade-Fichou MP, et al (2001). Telomerase inhibitors based on quadruplex ligands selected by a fluorescent assay. Proc Natl Acad Sci USA, 98, 3062-7.
32. Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J Immunol Methods, 65, 55-63.
33. Mousavi SH, Moallem SA, Mehri S, et al (2011) Improvement of cytotoxic and apoptogenic properties of crocin in cancer cell lines by its nanoliposomal form. Pharm Biol, 49, 1039-45.
34. Nair SC, Kurumboor SK, Hasegawa JH (1995). Saffron chemoprevention in biology and medicine, a review. Cancer Biother, 10, 257-64.
35. Nosrati M, Li S, Bagheri S, et al (2004). Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. Clinical Cancer Res, 10, 4983-90.
36. Ochiai T, Shimeno H, Mishima K, et al (2006). Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo. Biochim Biophys Acta, 1770, 578-84.
37. Papandreou MA, Kanakis CD, Polissiou MG, et al (2006). Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Agric Food Chem, 54, 8762-8.
38. Pham TQ, Cormier F, Farnworth E, et al (2000). Antioxidant properties of crocin from Gardenia jasminoides Ellis and study of the reactions of crocin with linoleic acid and crocin with oxygen. J Agric Food Chem, 48, 1455-61.
39. Schmidt M, Betti G, Hensel A (2007). Saffron in phytotherapy, pharmacology and clinical uses. Wien Med Wochenschr, 157, 315-9.
40. Shay JW, Wright WE (2002). Telomerase, a target for cancer therapeutics. Cancer Cell, 2, 257-65.
41. Smith LL, Coller HA, Roberts JM (2003). Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol, 5, 474-9.
42. Stewart CR (1968). Broadening by acridine orange of the thermal transition of DNA. Biopolymers, 6, 1737-43.
43. Sun J, Xu X, Ni C, et al (2011). Crocin inhibits proliferation and nucleic acid synthesis and induces apoptosis in the human tongue squamous cell carcinoma cell line Tca8113. Asian Pac J Cancer Prev, 12, 2679-83.
44. Wink M, Van Wyk BE (2008). Mind-Altering and Poisonous Plants of the World, Briza Publications, Pretoria, Medpharm Publishers, Germany, Timber Press, USA.
45. Yi-hsin HSU, Jing-jer LIN (2005). Telomere and telomerase as targets for anti-cancer and regeneration therapies. Acta Pharmacologica Sinica, 26, 513-8
46. Zheng YQ, Liu JX, Wang JN, et al (2006). Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia. Brain Res, 1138, 86-94.